VILAS PHARMACEUTICAL SERVICES ApS Financials, key figures and credit report
Gross profit 1 064.3 kDKK FY 2025 -3.8% vs 2024
EBIT 100.2 kDKK FY 2025 -31.2% vs 2024
Net debt - 181.9 kDKK FY 2025 +40% vs 2024
Quick ratio 3.6 FY 2025 -0.2 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 711.78 | 1 287.24 | 1 052.32 | 1 106.53 | 1 064.30 |
| Employee benefit expenses | - 625.39 | - 759.94 | - 856.55 | - 960.96 | - 964.08 |
| Total depreciation | -46.38 | -46.38 | |||
| EBIT | 40.00 | 480.92 | 195.77 | 145.57 | 100.22 |
| Other financial income | 0.80 | 0.29 | 0.84 | 1.20 | 5.10 |
| Other financial expenses | -7.89 | -18.76 | -8.58 | -16.23 | -6.29 |
| Net income from associates (fin.) | 14.31 | -9.98 | 23.89 | 17.15 | 17.12 |
| Pre-tax profit | 47.22 | 452.48 | 211.93 | 147.69 | 116.14 |
| Income taxes | -16.91 | - 107.51 | -44.51 | -45.82 | -38.52 |
| Net earnings | 30.31 | 344.97 | 167.42 | 101.87 | 77.63 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 139.15 | 92.77 | |||
| Tangible assets total | 139.15 | 92.77 | |||
| Holdings in group member companies | 20.00 | ||||
| Participating interests | 283.09 | 273.11 | 297.00 | 314.16 | 331.28 |
| Investments total | 283.09 | 273.11 | 297.00 | 314.16 | 351.28 |
| Non-current loans receivable | 86.00 | 75.80 | 72.00 | 61.60 | 80.97 |
| Long term receivables total | 86.00 | 75.80 | 72.00 | 61.60 | 80.97 |
| Inventories total | |||||
| Current trade debtors | 131.96 | 262.04 | 116.42 | 153.39 | 145.20 |
| Current amounts owed by group member comp. | 0.67 | ||||
| Current owed by particip. interest comp. | 11.75 | 11.75 | 11.61 | 11.61 | 11.61 |
| Prepayments and accrued income | 38.71 | 41.24 | |||
| Current other receivables | 6.63 | 4.43 | 16.51 | 0.92 | 10.20 |
| Short term receivables total | 150.35 | 278.22 | 183.25 | 207.16 | 167.69 |
| Cash and bank deposits | 52.04 | 242.45 | 338.85 | 303.37 | 181.94 |
| Cash and cash equivalents | 52.04 | 242.45 | 338.85 | 303.37 | 181.94 |
| Balance sheet total (assets) | 710.62 | 962.35 | 891.11 | 886.29 | 781.87 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Shares repurchased | 114.40 | 167.80 | 122.00 | 135.00 | 158.80 |
| Other reserves | 98.09 | 88.11 | 112.00 | 129.16 | 146.28 |
| Retained earnings | 240.32 | 112.80 | 311.87 | 327.14 | 253.09 |
| Profit of the financial year | 30.31 | 344.97 | 167.42 | 101.87 | 77.63 |
| Shareholders equity total | 533.11 | 763.68 | 763.30 | 743.17 | 685.80 |
| Provisions | 12.42 | 6.76 | 12.75 | 9.07 | |
| Non-current liabilities total | |||||
| Current trade creditors | 17.41 | 16.35 | 18.19 | 19.89 | 15.92 |
| Short-term deferred tax liabilities | 54.98 | 83.40 | 27.04 | 48.43 | 49.93 |
| Other non-interest bearing current liabilities | 92.70 | 92.16 | 69.83 | 65.73 | 30.23 |
| Current liabilities total | 165.09 | 191.91 | 115.06 | 134.05 | 96.08 |
| Balance sheet total (liabilities) | 710.62 | 962.35 | 891.11 | 886.29 | 781.87 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated